Control Group: Standard Western Treatment:DKD Standard Care

2 trials

Sponsors

China-Japan Friendship Hospital

Conditions

Diabetic Kidney Disease (DKDDiabetic Kidney Disease (DKD)

Unknown Phase

Adaptive Platform Clinical Study of Optimal Dosage of Tangshen Formula in Treating Diabetic Kidney Disease

Active, not recruitingITMCTR2026001423

China-Japan Friendship HospitalDiabetic Kidney Disease (DKD)

Start: 2026-07-09Updated: 2026-06-22

Adaptive Platform Clinical Study of Optimal Dosage of Tangshen Formula in Treating Diabetic Kidney Disease

Active, not recruitingChiCTR2600126263

China-Japan Friendship HospitalDiabetic Kidney Disease (DKD

Start: 2026-06-24Updated: 2026-06-08